OptimizeRx Corporation (OPRX)
USD 4.78
(-8.6%)
USD 4.78
(-8.6%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 22.97 Million USD | 227.8% |
| 2022 | -17.97 Million USD | 78.69% |
| 2021 | -84.35 Million USD | -737.84% |
| 2020 | -10.06 Million USD | 44.95% |
| 2019 | -18.28 Million USD | -105.17% |
| 2018 | -8.91 Million USD | -74.01% |
| 2017 | -5.12 Million USD | 27.18% |
| 2016 | -7.03 Million USD | 14.29% |
| 2015 | -8.2 Million USD | -138.11% |
| 2014 | -3.44 Million USD | -208.25% |
| 2013 | -1.11 Million USD | -293.38% |
| 2012 | -284.26 Thousand USD | 70.36% |
| 2011 | -959.16 Thousand USD | 24.95% |
| 2010 | -1.27 Million USD | -94.71% |
| 2009 | -656.39 Thousand USD | 73.73% |
| 2008 | -2.49 Million USD | -1399.21% |
| 2007 | 192.32 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 21.12 Million USD | -0.73% |
| 2024 Q1 | 21.28 Million USD | -7.35% |
| 2023 Q2 | -9.79 Million USD | 39.66% |
| 2023 Q3 | -9.77 Million USD | 0.21% |
| 2023 Q4 | 22.97 Million USD | 335.05% |
| 2023 Q1 | -16.23 Million USD | 9.7% |
| 2023 FY | 22.97 Million USD | 227.8% |
| 2022 Q3 | -41.07 Million USD | 52.85% |
| 2022 Q1 | -88.65 Million USD | -5.1% |
| 2022 Q2 | -87.11 Million USD | 1.74% |
| 2022 Q4 | -17.97 Million USD | 56.24% |
| 2022 FY | -17.97 Million USD | 78.69% |
| 2021 Q1 | -81.85 Million USD | -713.01% |
| 2021 Q3 | -84.69 Million USD | -1.39% |
| 2021 Q4 | -84.35 Million USD | 0.4% |
| 2021 FY | -84.35 Million USD | -737.84% |
| 2021 Q2 | -83.53 Million USD | -2.05% |
| 2020 Q1 | -14.67 Million USD | 19.76% |
| 2020 Q2 | -13.6 Million USD | 7.27% |
| 2020 FY | -10.06 Million USD | 44.95% |
| 2020 Q3 | -11.55 Million USD | 15.09% |
| 2020 Q4 | -10.06 Million USD | 12.86% |
| 2019 Q4 | -18.28 Million USD | 37.3% |
| 2019 FY | -18.28 Million USD | -105.17% |
| 2019 Q1 | -9.48 Million USD | -6.42% |
| 2019 Q2 | -29.91 Million USD | -215.36% |
| 2019 Q3 | -29.16 Million USD | 2.5% |
| 2018 Q4 | -8.91 Million USD | 34.08% |
| 2018 FY | -8.91 Million USD | -74.01% |
| 2018 Q1 | -4.29 Million USD | 16.08% |
| 2018 Q3 | -13.52 Million USD | -12.66% |
| 2018 Q2 | -12 Million USD | -179.25% |
| 2017 Q1 | -6.72 Million USD | 4.45% |
| 2017 Q2 | -5.84 Million USD | 13.07% |
| 2017 Q3 | -5.01 Million USD | 14.2% |
| 2017 Q4 | -5.12 Million USD | -2.18% |
| 2017 FY | -5.12 Million USD | 27.18% |
| 2016 Q2 | -7.56 Million USD | -0.25% |
| 2016 Q1 | -7.54 Million USD | 8.03% |
| 2016 Q3 | -7.57 Million USD | -0.1% |
| 2016 FY | -7.03 Million USD | 14.29% |
| 2016 Q4 | -7.03 Million USD | 7.13% |
| 2015 FY | -8.2 Million USD | -138.11% |
| 2015 Q1 | -3.51 Million USD | -1.85% |
| 2015 Q2 | -3.64 Million USD | -3.85% |
| 2015 Q3 | -8.17 Million USD | -124.21% |
| 2015 Q4 | -8.2 Million USD | -0.41% |
| 2014 Q1 | -4.03 Million USD | -260.45% |
| 2014 FY | -3.44 Million USD | -208.25% |
| 2014 Q4 | -3.44 Million USD | -5.73% |
| 2014 Q3 | -3.26 Million USD | 8.16% |
| 2014 Q2 | -3.54 Million USD | 11.93% |
| 2013 FY | -1.11 Million USD | -293.38% |
| 2013 Q1 | -260.39 Thousand USD | 8.4% |
| 2013 Q2 | -352.43 Thousand USD | -35.35% |
| 2013 Q3 | -486.69 Thousand USD | -38.1% |
| 2013 Q4 | -1.11 Million USD | -129.76% |
| 2012 Q2 | -527.51 Thousand USD | 33.85% |
| 2012 FY | -284.26 Thousand USD | 70.36% |
| 2012 Q4 | -284.26 Thousand USD | -0.58% |
| 2012 Q1 | -797.5 Thousand USD | 16.85% |
| 2012 Q3 | -282.63 Thousand USD | 46.42% |
| 2011 FY | -959.16 Thousand USD | 24.95% |
| 2011 Q1 | -148.92 Thousand USD | 88.35% |
| 2011 Q2 | 30.23 Thousand USD | 120.3% |
| 2011 Q3 | -1.01 Million USD | -3471.31% |
| 2011 Q4 | -959.16 Thousand USD | 5.9% |
| 2010 Q2 | -1.13 Million USD | -205.03% |
| 2010 FY | -1.27 Million USD | -94.71% |
| 2010 Q4 | -1.27 Million USD | -89.52% |
| 2010 Q3 | -674.37 Thousand USD | 40.48% |
| 2010 Q1 | -371.41 Thousand USD | 43.42% |
| 2009 Q2 | -1.33 Million USD | 26.43% |
| 2009 Q1 | -1.81 Million USD | 27.21% |
| 2009 FY | -656.39 Thousand USD | 73.73% |
| 2009 Q4 | -656.39 Thousand USD | 34.78% |
| 2009 Q3 | -1 Million USD | 24.79% |
| 2008 FY | -2.49 Million USD | -1399.21% |
| 2008 Q4 | -2.49 Million USD | 0.0% |
| 2007 FY | 192.32 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Inovalon Holdings, Inc. | 773.42 Million USD | 97.03% |
| GE HealthCare Technologies Inc. | 7.36 Billion USD | 99.688% |
| Sharecare, Inc. | -125.84 Million USD | 118.254% |
| Progyny, Inc. | -77.9 Million USD | 129.486% |
| Aclarion, Inc. | 94.65 Thousand USD | -24168.495% |
| CareMax, Inc. | 426.4 Million USD | 94.613% |
| Simulations Plus, Inc. | -9.83 Million USD | 333.544% |
| CareCloud, Inc. | 11.4 Million USD | -101.468% |
| Forian Inc. | 16.95 Million USD | -35.454% |
| Bullfrog AI Holdings, Inc. Warrants | -2.62 Million USD | 975.189% |
| Bullfrog AI Holdings, Inc. Common Stock | -2.62 Million USD | 975.189% |
| Minerva Surgical, Inc. | 32.74 Million USD | 29.854% |
| Omnicell, Inc. | 113.11 Million USD | 79.691% |
| Definitive Healthcare Corp. | 136.95 Million USD | 83.227% |
| Zhongchao Inc. | -6.74 Million USD | 440.794% |
| Accolade, Inc. | 55.93 Million USD | 58.928% |
| Streamline Health Solutions, Inc. | 7.37 Million USD | -211.434% |
| Ontrak, Inc. | -8.01 Million USD | 386.712% |
| SOPHiA GENETICS SA | -104.65 Million USD | 121.951% |
| R1 RCM Inc. | 1.56 Billion USD | 98.534% |
| Spok Holdings, Inc. | -20.9 Million USD | 209.895% |
| Privia Health Group, Inc. | -381.22 Million USD | 106.026% |
| EUDA Health Holdings Limited | 3.18 Million USD | -621.118% |
| HeartBeam, Inc. | -16.18 Million USD | 241.895% |
| GeneDx Holdings Corp. | 20.08 Million USD | -14.348% |
| TruBridge, Inc. | 199.44 Million USD | 88.482% |
| Nutex Health, Inc. | 253.75 Million USD | 90.947% |
| Renalytix Plc | 3.85 Million USD | -495.884% |
| Sharecare, Inc. | -125.84 Million USD | 118.254% |
| Health Catalyst, Inc. | 142.79 Million USD | 83.913% |
| 10x Genomics, Inc. | -263.91 Million USD | 108.704% |
| GoodRx Holdings, Inc. | 38.77 Million USD | 40.756% |
| SCWorx Corp. | -1077.00 USD | 2133001.021% |
| Schrödinger, Inc. | -33.18 Million USD | 169.224% |
| HealthEquity, Inc. | 529.16 Million USD | 95.659% |
| HealthStream, Inc. | -17.11 Million USD | 234.241% |
| MSP Recovery, Inc. | 667.69 Million USD | 96.56% |
| Augmedix, Inc. | -20.49 Million USD | 212.077% |
| BrightSpring Health Services, Inc. Common Stock | 3.65 Billion USD | 99.372% |
| Ontrak, Inc. | -8.01 Million USD | 386.712% |
| SHL Telemedicine Ltd. | 13.15 Million USD | -74.58% |
| CareCloud, Inc. | 11.4 Million USD | -101.468% |
| Premier, Inc. | 855 Thousand USD | -2586.707% |
| Certara, Inc. | 63.24 Million USD | 63.677% |
| GeneDx Holdings Corp. | 20.08 Million USD | -14.348% |
| OneMedNet Corporation | 5.05 Million USD | -354.49% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 3.65 Billion USD | 99.372% |
| EUDA Health Holdings Limited | 3.18 Million USD | -621.118% |
| HeartBeam, Inc. | -16.18 Million USD | 241.895% |
| CareCloud, Inc. | 11.4 Million USD | -101.468% |
| Mangoceuticals, Inc. | -610.32 Thousand USD | 3863.77% |
| CareMax, Inc. | 426.4 Million USD | 94.613% |
| Healthcare Triangle, Inc. | 3.08 Million USD | -645.097% |
| National Research Corporation | 32.3 Million USD | 28.888% |
| Aclarion, Inc. | 94.65 Thousand USD | -24168.495% |